Skip to content

Clinical trials

Overweight trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Malaysia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20141
20172
20181
20191
20203
20212
20235
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting2
Unknown status2
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S6
Universiti Tunku Abdul Rahman3
Malaysia Palm Oil Board2
Ministry of Health, Malaysia2
Swinburne University of Technology2
Universiti Sains Malaysia2
AstraZeneca1
Dr. Tikfu Gee1
Min-Tze LIONG1
Universiti Putra Malaysia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight23
Obesity15
Diabetes Mellitus, Type 23
Weight Loss3
Diabetes Mellitus1
Glucose Intolerance1
Hypoxia1
Insulin Resistance1
Postoperative Pain1
Prediabetic State1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.